Skip to Main Content

Author Details

R??my Robinot
Institut Pasteur, Universite Paris Cite, CNRS UMR 9
2012
17
10
Kirsten Obernier (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36859333Global loss of cellular m<sup>6</sup>A RNA methylation following infection with different SARS-CoV-2 variants.Genome Res2023
37559726Divergent adaptive immune responses define two types of long COVID.Front Immunol2023
37542391SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters<sup>1</sup>.Emerg Microbes Infect2023
35082297Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry.Nat Commun2022
36121299The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.J Virol2022
35027731BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2.Nat Cell Biol2022
34272374SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance.Nat Commun2021
33899033Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.Cell Rep Med2021
33501440BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2.bioRxiv2021
34601723SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation.EMBO J2021
34043588Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming.J Clin Invest2021
32645325The Global Phosphorylation Landscape of SARS-CoV-2 Infection.Cell2020
32817357A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.Sci Transl Med2020
30389696Chronic <i>Borrelia burgdorferi</i> infection triggers NKT lymphomagenesis.Blood2018
27069116CD1d-restricted peripheral T cell lymphoma in mice and humans.J Exp Med2016
23302741Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirus.Clin Vaccine Immunol2013
22840602Seroprevalence and cross-reactivity of human polyomavirus 9.Emerg Infect Dis2012
  • 1 - 17 of 17

Recommended Authors

Mir M Khalid
Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 38
Patrick Wong
Yale School of Medicine
Career Start Year 2016
Number of shared co-authors 0
Camille R Simoneau
Gladstone Institute of Virology
Career Start Year 2015
Number of shared co-authors 39
Roosheel S Patel
Icahn School of Medicine at Mount Sinai
Career Start Year 2015
Number of shared co-authors 7
Peiwen Lu
Yale University School of Medicine
Career Start Year 2013
Number of shared co-authors 0
Ann-Kathrin Reuschl
University College London
Career Start Year 2013
Number of shared co-authors 17
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 2
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 10
Siyuan Ding
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 4
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 1
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 20
Vineet D Menachery
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 0
Jacob D Eccles
University of Illinois at Chicago
Career Start Year 2008
Number of shared co-authors 0
Mohsan Saeed
Boston University Chobanian and Avedisian School of Medicine
Career Start Year 2007
Number of shared co-authors 2
Stephanie A Montgomery
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Career Start Year 2006
Number of shared co-authors 1
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 1
Yaw Shin Ooi
Duke-NUS Medical School
Career Start Year 2003
Number of shared co-authors 4
Lisa E Gralinski
University of North Carolina at Chapel Hill
Career Start Year 2002
Number of shared co-authors 0
Charles S Dela Cruz
Department of Microbial Pathogenesis Yale University New Haven
Career Start Year 1998
Number of shared co-authors 0
Robert H Carnahan
Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 0
Renee C Ireton
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1997
Number of shared co-authors 1
Ellen F Foxman
Yale School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Benhur Lee
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 8
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 41
Lucy Thorne
University College London
Career Start Year 1992
Number of shared co-authors 13
Chien-Te K Tseng
The University of Texas Medical Branch
Career Start Year 1991
Number of shared co-authors 0
Akiko Iwasaki
Yale University
Career Start Year 1990
Number of shared co-authors 2
Nir Hacohen
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 4
Bart L Haagmans
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 1
Ralph S Baric
University of North Carolina
Career Start Year 1981
Number of shared co-authors 1

Collaborators

Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Co-authored papers 6
Marco Vignuzzi
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 3
Veronica V Rezelj
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 3
Benjamin R tenOever
NYU Grossman School of Medicine
Co-authored papers 3
Bruce R Conklin
Gladstone Institutes
Co-authored papers 2
Jonathan S Weissman
Whitehead Institute for Biomedical Research
Co-authored papers 2
Martin Kampmann
Institute for Neurodegenerative Diseases, University of California san francisco
Co-authored papers 2
Kevin Holden
Synthego Corporation
Co-authored papers 2
Jennifer Oki
Synthego Corporation
Co-authored papers 2
Avi J Samelson
Institute for Neurodegenerative Diseases, University of California san francisco
Co-authored papers 2
James A Wells
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 2
Jared Carlson-Stevermer
Synthego Corporation
Co-authored papers 2
Irene Lui
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 2
Travis J Maures
University of Michigan Medical School ann arbor
Co-authored papers 2
Benjamin J Polacco
Co-authored papers 1
Jeffrey Z Guo
Co-authored papers 1
Jiewei Xu
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Aurelien Dugourd
Institute of Experimental Medicine and Systems Biology, RWTH Aachen University
Co-authored papers 1
Robyn M Kaake
J. David Gladstone Institutes
Co-authored papers 1
Svenja Ulferts
University of Freiburg
Co-authored papers 1
Kevan M Shokat
University of California San Francisco
Co-authored papers 1
Ruth H??ttenhain
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 1
Beril Tutuncuoglu
University of California san francisco
Co-authored papers 1
Georg Kochs
Institute of Virology, Freiburg University Medical Center, University of Freiburg
Co-authored papers 1
You-Qiang Song
The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University
Co-authored papers 1
Quang Dinh Tran
CNRS UMR 3569, Institut Pasteur
Co-authored papers 1
Jean K Lim
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
R Dyche Mullins
University of California San Francisco, USA Howard Hughes Medical Institute
Co-authored papers 1
Maxime Chazal
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Co-authored papers 1
Release 1.2